Divi's Laboratories Limited
Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients
What Divi's files
- Others53
- Investor Meet24
- Board Meeting9
- Important9
- Dividend/Bonus4
- Results1
Divi's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 10, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
Divi's Labs reported Q1 FY27 consolidated revenue of ₹3,144 Cr (up from ₹2,529 Cr YoY) and PAT of ₹902 Cr (up from ₹545 Cr YoY), with 10% constant currency standalone revenue growth. Custom Synthesis drove 60% of revenue. Management is confident in achieving double-digit growth, propelled by three major capex...
Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
Audio recording of the Q1 FY27 earnings conference call, covering the quarter ended June 30, 2026, is now available on the company's website for investor access.
Divi's Laboratories Limited has informed the Exchange about change in Senior Management.